Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRTAP9-4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ABHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF264 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100131303 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCE2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAXO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL31RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100128751 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC729970 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on